换一批Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial
第一作者：
Toi, Masakazu
作者：
Toi, Masakazu [1]
;
Imoto, Shigeru [2]
;
Ishida, Takanori [3]
;
Ito, Yoshinori [4]
;
Iwata, Hiroji [5]
;
Masuda, Norikazu [6]
;
Mukai, Hirofumi [7]
;
Saji, Shigehira [8]
;
Shimizu, Akira [9]
;
Ikeda, Takafumi [10]
;
Haga, Hironori [11]
;
Saeki, Toshiaki [12]
;
Aogi, Kenjiro [13]
;
Sugie, Tomoharu [14]
;
Ueno, Takayuki [15]
;
Kinoshita, Takayuki [16]
;
Kai, Yuichiro [17]
;
Kitada, Masahiro [18]
;
Sato, Yasuyuki [19]
;
Jimbo, Kenjiro ;
Sato, Nobuaki ;
Ishiguro, Hiroshi ;
Takada, Masahiro ;
Ohashi, Yasuo ;
Ohno, Shinji
作者单位：
Kyoto Univ Hosp, Breast Canc Unit, Grad Sch Med, Kyoto, Japan
[1]
Kyorin Univ Hosp, Mitaka, Tokyo, Japan
[2]
Tohoku Univ, Sendai, Miyagi, Japan
[3]
Canc Inst Hosp, Tokyo, Japan
[4]
Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[5]
Natl Hosp Org Osaka Natl Hosp, Osaka, Japan
[6]
Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[7]
Fukushima Med Univ, Fukushima, Japan
[8]
Saitama Med Univ, Int Med Ctr, Hidaka, Japan
[9]
Natl Hosp Org Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[10]
Kansai Med Univ Hosp, Hirakata, Osaka, Japan
[11]
Natl Hosp Org Tokyo Med Ctr, Tokyo, Japan
[12]
Ueo Breast Surg Clin, Oita, Japan
[13]
Asahikawa Med Univ Hosp, Asahikawa, Hokkaido, Japan
[14]
Natl Hosp Org Nagoya Med Ctr, Nagoya, Aichi, Japan
[15]
Natl Canc Ctr, Tokyo, Japan
[16]
Niigata Canc Ctr Hosp, Niigata, Japan
[17]
Int Univ Hlth & Welf, Narita Hosp, Narita, Japan
[18]
Chuo Univ, Tokyo, Japan
[19]
发布时间
2022-09-11
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
